21005-60-7

Usage

Uses

Used in the Food Industry:
RARECHEM AN KA 0030 is used as a preservative to prevent the oxidation of food products, ensuring their freshness and extending their shelf life.
Used in the Cosmetic Industry:
RARECHEM AN KA 0030 is used as an antioxidant in cosmetic products to protect them from oxidation, which helps maintain their quality and effectiveness over time.
Used in the Plastics Industry:
RARECHEM AN KA 0030 is used as a stabilizer in the production of plastics to improve their stability and durability, ensuring that they maintain their properties under various conditions.
Used in the Rubber Industry:
RARECHEM AN KA 0030 is used as an additive in the production of rubber to enhance its stability and durability, making it more resistant to wear and tear.
RARECHEM AN KA 0030 is considered to be relatively low in toxicity and is generally safe for use in consumer products when used in accordance with regulatory guidelines, making it a preferred choice for various applications across different industries.

Upstream product

• 87149-49-3 5-(2-nitro-ethyl)-1H-indole 
• 21005-48-1 5-(2-nitro-vinyl)-1H-indole 
• 1196-69-6 1H-indole-5-carboxaldehyde 

Downstream Products

• 1239447-44-9 N-(2-(1H-indol-5-yl)ethyl)-2-(3-benzoylphenyl)propanamide 

Relevant academic research and scientific papers

PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to pyrimidine derivatives of formula (I) wherein (R1)n, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.

4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in?vitro and in?vivo

A series of 4,5-indolyl-N-hydroxyphenylacrylamides, as HDAC inhibitors, has been synthesized and evaluated in?vitro and in?vivo. 4-Indolyl compounds 13 and 17 functions as potent inhibitors of HDAC1 (IC50 1.28?nM and 1.34?nM) and HDAC 2 (ICsub

2-(AMINO-SUBSTITUTED)-4-ARYL PYRAMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES

A heterocyclic inhibitor having the formula (I), with the variables defined herein, which is useful for treating inflammatory and other physiological disorders in which PKC-theta isoform plays a role.